CIZ Stock Overview
Develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Cizzle Biotechnology Holdings Plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.018 |
| 52 Week High | UK£0.034 |
| 52 Week Low | UK£0.014 |
| Beta | 0.37 |
| 11 Month Change | -17.09% |
| 3 Month Change | 11.41% |
| 1 Year Change | -13.05% |
| 33 Year Change | -56.52% |
| 5 Year Change | n/a |
| Change since IPO | -80.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| CIZ | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | -1.0% | -5.2% | 1.0% |
| 1Y | -13.0% | -19.8% | 6.3% |
Return vs Industry: CIZ exceeded the UK Biotechs industry which returned -19.8% over the past year.
Return vs Market: CIZ underperformed the UK Market which returned 6.3% over the past year.
Price Volatility
| CIZ volatility | |
|---|---|
| CIZ Average Weekly Movement | 8.3% |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: CIZ's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: CIZ's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 4 | n/a | www.cizzlebiotechnology.com |
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Cizzle Biotechnology Holdings Plc Fundamentals Summary
| CIZ fundamental statistics | |
|---|---|
| Market cap | UK£6.74m |
| Earnings (TTM) | -UK£2.70m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-2.6x
P/E RatioIs CIZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CIZ income statement (TTM) | |
|---|---|
| Revenue | UK£0 |
| Cost of Revenue | UK£0 |
| Gross Profit | UK£0 |
| Other Expenses | UK£2.70m |
| Earnings | -UK£2.70m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0068 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did CIZ perform over the long term?
See historical performance and comparison